5-[2-[2-(3,5-difluorophenyl)-1-[[2-(5,6-dimethylindazol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide
C31H26F3N5O2 — CID 71186840
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[2-[2-(3,5-difluorophenyl)-1-[[2-(5,6-dimethylindazol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide
5-[2-[2-(3,5-difluorophenyl)-1-[[2-(5,6-dimethylindazol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide (PubChem CID 71186840) has the molecular formula C31H26F3N5O2 and a molecular weight of 557.58 g/mol. Its IUPAC name is 5-[2-[2-(3,5-difluorophenyl)-1-[[2-(5,6-dimethylindazol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide.
Molecular Properties
| Compound Name | 5-[2-[2-(3,5-difluorophenyl)-1-[[2-(5,6-dimethylindazol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide |
|---|---|
| PubChem CID | 71186840 |
| Molecular Formula | C31H26F3N5O2 |
| Molecular Weight | 557.58 g/mol |
| Exact Mass | 557.20 |
| IUPAC Name | 5-[2-[2-(3,5-difluorophenyl)-1-[[2-(5,6-dimethylindazol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide |
| SMILES | Cc1cc2cnn(CC(=O)NC(Cc3cc(F)cc(F)c3)c3ncccc3-c3ccc(F)c(C(N)=O)c3)c2cc1C |
| InChI | InChI=1S/C31H26F3N5O2/c1-17-8-21-15-37-39(28(21)9-18(17)2)16-29(40)38-27(12-19-10-22(32)14-23(33)11-19)30-24(4-3-7-36-30)20-5-6-26(34)25(13-20)31(35)41/h3-11,13-15,27H,12,16H2,1-2H3,(H2,35,41)(H,38,40) |
| InChIKey | WNWTXMXTWOFGGZ-UHFFFAOYSA-N |
| XLogP | 5.33 |
| TPSA | 102.90 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 557.58 |
| LogP ≤ 5 | 5.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71186840 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.